HeartFlow Inc. is a commercial-stage medical technology company that has pioneered the use of software and artificial intelligence (AI) to deliver a non-invasive solution for diagnosing and managing coronary artery disease (CAD). The Company’s novel HeartFlow Platform uses AI and advanced computational fluid dynamics to create a personalized three-dimensional (3D) model of a patient’s heart based on a single coronary computed tomography angiography (CCTA). Its AI-driven platform includes Roadmap Analysis, FFRCT Analysis and Plaque Analysis. The HeartFlow FFRCT Analysis and Plaque Analysis software assists physicians in diagnosing, managing and delivering precision care to patients with CAD. The RoadMap Analysis offers a highly intuitive anatomic visualization of the coronary arteries, helping physicians quickly identify clinically relevant areas to focus their review.
Company Information
About this company
Key people
John C. M. Farquhar
President, Chief Executive Officer, Director
Vikram Verghese
Chief Financial Officer
Campbell D. K. Rogers
Chief Medical Officer
William C. Weldon
Independent Chairman of the Board
Nicholas Downing
Director
Charles A. Taylor
Director
Timothy Barabe
Independent Director
Julie A. Cullivan
Independent Director
Click to see more
Key facts
- Shares in issue85.16m
- EPICHTFL
- ISINUS42238D1072
- LocationUnited States
- SectorTechnology
- IndustrySoftware & Programming
- Market cap$2.40bn
- Employees699
- ExchangeNASDAQ
- Index
- Website
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.